BLOG

Regeneus secures ethics approval to collect stem cells for off-the-shelf … – Proactive Investors Australia

Proactive Investors AustraliaRegenerative medicine company Regeneus (ASX: RGS) has received the key ethics approval to collect stem cells from human donors for the production of its new allogeneic off-the-shelf stem cell product for osteoarthritis. It can now begin manufacturing …Regeneus scores stem cells ethics approvalFinance News Network all 2 news articles …read more   &nbs… Continue reading

2014-04-07 NEWS

Abnormal blood stem cells reprogram their environment – HealthCanal.com

Abnormal blood stem cells reprogram their environmentHealthCanal.comby Koh – Blood arises from stem cells in the bone marrow; in patients with a myelodysplastic disorder (MDS), defective stem cells reprogram their neighbors in the marrow to create a “niche” that promotes their own survival. A recent report by …Stem cell transplantation from unrelated donor saves 2-year-oldTimes … Continue reading

2014-04-07 NEWS

Bonus BioGroup Gains From Start of Clinical Trials of Stem Cell Derived Bone … – Jewish Business News

Bonus BioGroup Gains From Start of Clinical Trials of Stem Cell Derived Bone …Jewish Business NewsBonus Biogroup Ltd. (TASE: BONS), which has developed a method for producing bone grafts from stem cells, has begun a clinical trial of jawbone grafts. The trial’s interim results are due in four months. Bonus Biogroup’s share price rose 10.4% … Continue reading

2014-04-07 NEWS